-
Innovation Ranking
NewInnovation Ranking – Biodesix Inc
Biodesix Inc (Biodesix) is a molecular diagnostics company which discovers, develops and commercializes multivariate protein and genomic diagnostic blood tests in oncology for patients and doctors to enable precision medicine. These tests are used for early detection of diseases, diagnosis accuracy, disease monitoring and also provide improved therapeutic guidance for cancer patients. Biodesix’s product portfolio includes GeneStrat, a gene panel of clinically actionable mutations for tumor profiling for patients with advanced lung cancer; and VeriStrat, a serum proteomic test for...
-
Company Profile
Biodesix Inc – Company Profile
Biodesix Inc (Biodesix) discovers, develops and commercializes testing solutions for lung Diseases. The company offers its services for early detection of diseases, diagnosis accuracy and disease monitoring and also provides improved therapeutic guidance for cancer patients. Biodesix’s product portfolio includes GeneStrat, a gene panel of clinically actionable mutations for tumor profiling for patients with advanced lung cancer and VeriStrat, a serum proteomic test for patients with non-small cell lung cancer. The company collaborates with researchers to develop companion diagnostics for...
Add to Basket -
Product Insights
NewBiodesix Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Biodesix Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Biodesix Inc (Biodesix) is a molecular diagnostics company which discovers, develops and commercializes multivariate protein and genomic diagnostic blood tests in oncology for patients and doctors to enable precision medicine. These tests are used for early detection of diseases, diagnosis accuracy, disease monitoring and also provide improved therapeutic guidance for cancer patients. Biodesix’s product portfolio includes GeneStrat, a gene panel...
-
Product Insights
Immunochemistry Rapid Tests and POC Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update
Spot test kits intended generally for rapid diagnosis, with immediate results, through immuno assays. Some of the tests carried out using immunochemistry rapid test include rabies virus test, allergenic food proteins, and enteric infection. The immunochemistry rapid tests and POC pipeline market research report provides comprehensive information about the immunochemistry rapid tests and POC pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
-
Track & Monitor
Genomics in Healthcare: Molecular Diagnosis Biomarkers
Innovations in healthcare industry is relentless, making it hard to stay-on top of the dynamically evolving industry landscape and in early identification of profound shifts posing high risk of being disrupted if detected too late. GlobalData's coherent data-driven approach, using multiple forward-looking alternative datasets, empowers clients by decoding in advance the disruptive innovations in healthcare industry. Using patent data, GlobalData's proprietary industry innovation s-curve identifies specific innovation areas and their stage of evolution, i.e., whether they are emerging, accelerating or...
-
Track & Monitor
Artificial Intelligence in Healthcare: Automated Immunoassay Analyzer
Innovations in healthcare industry is relentless, making it hard to stay-on top of the dynamically evolving industry landscape and in early identification of profound shifts posing high risk of being disrupted if detected too late. GlobalData's coherent data-driven approach, using multiple forward-looking alternative datasets, empowers clients by decoding in advance the disruptive innovations in healthcare industry. Using patent data, GlobalData's proprietary industry innovation s-curve identifies specific innovation areas and their stage of evolution, i.e., whether they are emerging, accelerating or...
-
Track & Monitor
Cloud in Healthcare: Automated Immunoassay Analyzer
Innovations in healthcare industry is relentless, making it hard to stay-on top of the dynamically evolving industry landscape and in early identification of profound shifts posing high risk of being disrupted if detected too late. GlobalData's coherent data-driven approach, using multiple forward-looking alternative datasets, empowers clients by decoding in advance the disruptive innovations in healthcare industry. Using patent data, GlobalData's proprietary industry innovation s-curve identifies specific innovation areas and their stage of evolution, i.e., whether they are emerging, accelerating or...
-
Track & Monitor
Environment Sustainability in Healthcare: Automated Immunoassay Analyzer
Innovations in healthcare industry is relentless, making it hard to stay-on top of the dynamically evolving industry landscape and in early identification of profound shifts posing high risk of being disrupted if detected too late. GlobalData's coherent data-driven approach, using multiple forward-looking alternative datasets, empowers clients by decoding in advance the disruptive innovations in healthcare industry. Using patent data, GlobalData's proprietary industry innovation s-curve identifies specific innovation areas and their stage of evolution, i.e., whether they are emerging, accelerating or...
-
Track & Monitor
Internet of Things in Healthcare: Automated Immunoassay Analyzer
Innovations in healthcare industry is relentless, making it hard to stay-on top of the dynamically evolving industry landscape and in early identification of profound shifts posing high risk of being disrupted if detected too late. GlobalData's coherent data-driven approach, using multiple forward-looking alternative datasets, empowers clients by decoding in advance the disruptive innovations in healthcare industry. Using patent data, GlobalData's proprietary industry innovation s-curve identifies specific innovation areas and their stage of evolution, i.e., whether they are emerging, accelerating or...